Gabapentin
- Product NDC
- 0615-8233
- 11-digit product format
- 006158233
- Labeler code
- 0615
- Product ID
- 0615-8233_ec2102c6-c800-4b3b-b4e6-4029fb6077bb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA077662
- Marketing category
- ANDA
- Marketing start
- 2006-04-01
- Marketing end
- 2024-08-31
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8233-05 | 00615823305 | 15 TABLET in 1 BLISTER PACK (0615-8233-05) | 15 tablet | 2019-06-13 | 0000-00-00 | No | No | Current |
| 0615-8233-30 | 00615823330 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8233-30) > 5 TABLET in 1 BLISTER PACK | 6 blister pack | 2019-06-18 | 0000-00-00 | No | No | Current |
| 0615-8233-39 | 00615823339 | 30 TABLET in 1 BLISTER PACK (0615-8233-39) | 30 tablet | 2019-06-13 | 0000-00-00 | No | No | Current |